IL6 and obesity disorder: Obesity promotes insulin resistance by resulting in a state of chronic inflammation that involves production of proinflammatory cytokines (TNF-α, IL-6), an increase in the number of macrophages, and activation of a complex cascade of signaling events in muscle, fat and liver tissues [6], [35], [42].